Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironment

1 Dec 2021

Abstract excerpt

Background: Breast cancer (BRCA) is the leading cause of cancer death among females. Studies suggested that β-adrenoceptors involved in tumor progression by regulating immune system. However, how ADRB2 affects the immune infiltration in BRCA is still being unraveled. Methods: Expressions of ADRB2 in multiple tissues, cancers and blood cells were analyzed by using the Human Protein Atlas and UALCAN database....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Stress, Anesthesia, and Immune Response
Share to Stress Responses and Cortisol
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35116377
DOI: 10.21037/tcr-21-1257

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironmentPMID 35116377Read ↗

ADRB2 Expression Predicts the Clinical Outcomes and is Associated with Immune Cells Infiltration in Lung AdenocarcinomaSemantic proximity Read ↗

ADRB2 expression predicts the clinical outcomes and is associated with immune cells infiltration in lung adenocarcinomaSemantic proximity Read ↗

ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration.Semantic proximity Read ↗

Comprehensive Analysis of the Immune Microenvironment Reveals that CD52 is a Marker for Breast Cancer Treatment with Immune Checkpoint InhibitorsSemantic proximity Read ↗

Identification of a novel gene signature with DDR and EMT difunctionalities for predicting prognosis, immune activity, and drug response in breast cancerSemantic proximity Read ↗

Construction and Validation of Immune-Related LncRNA Signature to Predict the Prognosis and Therapeutic Efficacy of Breast CancerSemantic proximity Read ↗

SARS-CoV-2 receptor ACE2 identifies immuno-hot tumors in breast cancerSemantic proximity Read ↗

CD52 is a prognostic biomarker and correlated with immune features in breast cancerSemantic proximity Read ↗

Comprehensive tissue-specific gene set enrichment analysis and transcription factor analysis of breast cancer by integrating 14 gene expression datasets.Semantic proximity Read ↗

Identification of the new molecular subtypes related to inflammation in breast cancer.Semantic proximity Read ↗

Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer.Semantic proximity Read ↗

Novel Immune Subtypes Identification of HER2 Positive Breast Cancer Based On Immunogenomic LandscapeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.